Huining Cao

Director/Board Member at China Nuokang Bio-Pharmaceutical, Inc.

58 year

Consumer Services

Health Technology

Profile

Huining Cao is an Independent Director at China Nuokang Bio-Pharmaceutical, Inc. since 2010.
He is also currently serving as the Academic Director-Finance & Professor-Finance at Cheung Kong Graduate School of Business.
Previously, he held positions as a Professor at Carnegie Mellon University, The Ohio State University, the University of California, Berkeley, the University of California San Diego, and The University of North Carolina at Charlotte.
Dr. Cao holds a doctorate degree from the University of California, Los Angeles and Yale University.

Huining Cao active positions

Companies	Position	Start
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Director/Board Member	2010-08-26
Cheung Kong Graduate School of Business	Corporate Officer/Principal	2010-12-12

All active positions of Huining Cao

Former positions of Huining Cao

Companies	Position	End
The University of North Carolina at Charlotte	Corporate Officer/Principal	-
Carnegie Mellon University Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.	Corporate Officer/Principal	-
University of California San Diego	Corporate Officer/Principal	-
The Ohio State University The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.	Corporate Officer/Principal	-
University of California, Berkeley	Corporate Officer/Principal	-

See the detail of Huining Cao's experience

Training of Huining Cao

University of California, Los Angeles	Doctorate Degree
Yale University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Huining Cao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
China Nuokang Bio-Pharmaceutical, Inc. China Nuokang Bio-Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology China Nuokang Bio-Pharmaceutical, Inc. is a biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. It currently sells a portfolio of fourteen products, including three principal products: Baquting, its flagship bleeding control product; Aiduo, its cardiovascular stress imaging agent; and Aiwen, its anti-arrhythmic agent. The company has also entered into an exclusive agreement for the marketing and distribution in China of Kaitong, an intravenous injectable lipid emulsion of vasodilator alprostadil for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis. Its product pipeline includes four product candidates under development that address the growing market and medical needs for hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. The company was founded on November 1997 and is headquartered in Shenyang, China.	Health Technology